Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Capital Reinvestment Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Capital Reinvestment Ratio of 1.21x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥24.79 Million) in capital expenditures (CN¥29.92 Million). See Shandong Sanyuan Biotechnology Co.Ltd. (301206) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Capital Reinvestment Ratio (2013–2023)
This chart tracks Shandong Sanyuan Biotechnology Co.Ltd.'s Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2023)
Year-by-year Capital Reinvestment Ratio for Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2023. For live market cap and broader valuation context, see Shandong Sanyuan Biotechnology Co.Ltd. (301206) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | CN¥57.31 Million | CN¥122.99 Million | ▼ -25.5% |
| 2022 | 2.88x | CN¥84.26 Million | CN¥242.67 Million | ▲ +325.7% |
| 2021 | 0.68x | CN¥642.08 Million | CN¥434.37 Million | ▼ -3.1% |
| 2020 | 0.70x | CN¥217.37 Million | CN¥151.76 Million | ▼ -26.0% |
| 2019 | 0.94x | CN¥149.21 Million | CN¥140.73 Million | ▲ +26.9% |
| 2018 | 0.74x | CN¥65.46 Million | CN¥48.65 Million | ▼ -68.2% |
| 2017 | 2.34x | CN¥20.25 Million | CN¥47.35 Million | ▲ +334.8% |
| 2016 | 0.54x | CN¥22.96 Million | CN¥12.35 Million | ▼ -45.8% |
| 2015 | 0.99x | CN¥9.50 Million | CN¥9.43 Million | ▼ -77.4% |
| 2014 | 4.40x | CN¥3.20 Million | CN¥14.05 Million | ▲ +1130.7% |
| 2013 | 0.36x | CN¥3.89 Million | CN¥1.39 Million | — |